Role of vitamin D deficiency in cardiovascular disease

Heart

Volumn 98, Issue 8, 2012, Pages 609-614

  Reid, Ian R ^a   Bolland, Mark J ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; CALCIUM; COLECALCIFEROL; PLACEBO; VITAMIN D; VITAMIN D RECEPTOR;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TREATMENT FAILURE; EVIDENCE BASED MEDICINE; HEART INFARCTION; HUMAN; NONHUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; STROKE; TREATMENT DURATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN METABOLISM;

BIOMEDICAL RESEARCH; CARDIOVASCULAR DISEASES; DIETARY SUPPLEMENTS; HUMANS; REFERENCE VALUES; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84860148992     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2011-301356     Document Type: Review

References (57)

1. Bouillon R, Carmeliet G, Verlinden L, et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 2008;29:726-76.
2. Tiosano D, Schwartz Y, Braver Y, et al. The renineangiotensin system, blood pressure, and heart structure in patients with hereditary vitamin D-resistance rickets (HVDRR). J Bone Miner Res 2011;26:2252-60.
3. Wortsman J, Matsuoka LY, Chen TC, et al. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000;72:690-3. (Pubitemid 30667088)
4. Reid IR. Vitamin D. In: Martini L, ed. Encyclopedia of Endocrinology. San Diego: Academic Press, 2004:657-65.
5. Need AG, O'Loughlin PD, Morris HA, et al. Vitamin D metabolites and calcium absorption in severe vitamin D deficiency. J Bone Miner Res 2008;23:1859-63.
6. Wang YJ, DeLuca HF. Is the vitamin D receptor found in muscle? Endocrinology 2011;152:354-63.
7. Thacher TD, Fischer PR, Pettifor JM, et al. A comparison of calcium, vitamin D, or both for nutritional rickets in Nigerian children. N Engl J Med 1999;341:563-8. (Pubitemid 29384164)
8. Steingrimsdottir L, Gunnarsson O, Indridason OS, et al. Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA 2005;294:2336-41. (Pubitemid 41607410)
9. Hirani V, Tull K, Ali A, et al. Urgent action needed to improve vitamin D status among older people in England! Age Ageing 2010;39:62-8.
10. Jacques PF, Felson DT, Tucker KL, et al. Plasma 25-hydroxyvitamin d and its determinants in an elderly population sample. Am J Clin Nutr 1997;66:929-36. (Pubitemid 27415579)
11. Bolland MJ, Grey AB, Ames RW, et al. Determinants of vitamin D status in older men living in a subtropical climate. Osteoporos Int 2006;17:1742-8. (Pubitemid 44607394)
12. Lips P, Duong T, Oleksik A, et al. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the Multiple Outcomes of Raloxifene Evaluation clinical trial. J Clin Endocrinol Metab 2001;86:1212-21. (Pubitemid 32323007)
13. van der Wielen RP, Lowik MR, Vandenberg H, et al. Serum vitamin D concentrations among elderly people in Europe. Lancet 1995;346:207-10.
14. Bacon CJ, Gamble GD, Horne AM, et al. High-dose oral vitamin D3 supplementation in the elderly. Osteoporos Int 2009;20:1407-15.
15. Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005;293:2257-64. (Pubitemid 40629192)
16. Committee to Review Dietary Reference Intakes for Vitamin D and Calcium. Dietary Reference Intakes for Calcium and Vitamin D. Washington DC: Institute of Medicine, 2010.
17. Heaney RP. Assessing vitamin D status. Curr Opin Clin Nutr Metab Care 2011;14:440-4.
18. Dawson-Hughes B, Mithal A, Bonjour JP, et al. IOF position statement: vitamin D recommendations for older adults. Osteoporos Int 2010;21:1151-4.
19. Maxmen A. The vitamin D-lemma. Nature 2011;475:23-5.
20. Munger KL, Levin LI, Hollis BW, et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006;296:2832-8. (Pubitemid 44969183)
21. Cauley JA, LaCroix AZ, Wu L, et al. Serum 25-hydroxyvitamin D concentrations and risk for hip fractures. Ann Intern Med 2008;149:242-50.
22. Abrahamsen B, Masud T, Avenell A, et al. Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe. BMJ 2010;340:B5463.
23. Grandi NC, Breitling LP, Brenner H. Vitamin D and cardiovascular disease: systematic review and meta-analysis of prospective studies. Prev Med 2010;51:228-33.
24. Melamed ML, Michos ED, Post W, et al. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 2008;168:1629-37.
25. Ford ES, Zhao GX, Tsai J, et al. Vitamin D and all-cause mortality among adults in USA: findings from the national health and nutrition examination survey linked mortality study. Int J Epidemiol 2011;40:998-1005.
26. Sneve M, Figenschau Y, Jorde R. Supplementation with cholecalciferol does not result in weight reduction in overweight and obese subjects. Eur J Endocrinol 2008;159:675-84.
27. Reid D, Toole BJ, Knox S, et al. The relation between acute changes in the systemic inflammatory response and plasma 25-hydroxyvitamin D concentrations after elective knee arthroplasty. Am J Clin Nutr 2011;93:1006-11.
28. Grey A, Bolland M. Vitamin D: a place in the sun? Arch Intern Med 2010;170:1099-100.
29. Christakos S, DeLuca HF. Minireview: vitamin D: is there a role in extraskeletal health? Endocrinology 2011;152:2930-6.
30. Boucher BJ, Mannan N, Noonan K, et al. Glucose-intolerance and impairment of insulin-secretion in relation to vitamin-d deficiency in East London Asians. Diabetologia 1995;38:1239-45.
31. Billaudel BJ, Delbancut AP, Sutter BC, et al. Stimulatory effect of 1,25-dihydroxyvitamin-D(3) on calcium handling and insulin-secretion by islets from vitamin-D(3)-deficient rats. Steroids 1993;58:335-41.
32. Oh J, Weng S, Felton SK, et al. 1,25(OH)(2) vitamin D inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation 2009;120:687-98.
33. Chen SC, Law CS, Grigsby CL, et al. A role for the cell cycle phosphatase Cdc25a in vitamin D-dependent inhibition of adult rat vascular smooth muscle cell proliferation. J Steroid Biochem Mol Biol 2010;122:326-32.
34. Martinesi M, Bruni S, Stio M, et al. 1,25-Dihydroxyvitamin D-3 inhibits tumor necrosis factor-alpha-induced adhesion molecule expression in endothelial cells. Cell Biol Int 2006;30:365-75.
35. Xiang W, Kong J, Chen SC, et al. Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renineangiotensin systems. Am J Physiol Endocrinol Metab 2005;288:E125-32. (Pubitemid 40023798)
36. Al Mheid I, Patel R, Murrow J, et al. Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans. J Am Coll Cardiol 2011;58:186-92.
37. Williams DM, Fraser A, Lawlor DA. Associations of vitamin D, parathyroid hormone and calcium with cardiovascular risk factors in US adolescents. Heart 2011;97:315-20.
38. He JL, Scragg RK. Vitamin D, parathyroid hormone, and blood pressure in the national health and nutrition examination surveys. Am J Hypertens 2011;24:911-17.
39. Scragg R, Sowers MF, Bell C. Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the third National Health and Nutrition Examination Survey. Am J Hypertens 2007;20:713-19. (Pubitemid 46936167)
40. Forman JP, Giovannucci E, Holmes MD, et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007;49:1063-9. (Pubitemid 351664326)
41. Burgaz A, Orsini N, Larsson SC, et al. Blood 25-hydroxyvitamin D concentration and hypertension: a meta-analysis. J Hypertens 2011;29:636-45.
42. Pittas AG, Chung M, Trikalinos T, et al. Systematic review: vitamin D and cardiometabolic outcomes. Ann Intern Med 2010;152:307-14.
43. Bolland MJ, Bacon CJ, Horne AM, et al. Vitamin D insufficiency and health outcomes over 5 y in older women. Am J Clin Nutr 2010;91:82-9.
44. Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial [see comment]. BMJ 2003;326:469.
45. Elamin MB, Abu Elnour NO, Elamin KB, et al. Vitamin D and cardiovascular outcomes: a systematic review and meta-Analysis. J Clin Endocrinol Metab 2011;96:1931-42.
46. Bolland MJ, Grey A, Gamble GD, et al. Calcium/vitamin D supplements and health outcomes: a re-analysis of the women's health initiative limited-access dataset. Am J Clin Nutr 2011;94:1144-9.
47. Bolland MJ, Avenell A, Baron JA, et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ 2010;341:C3691.
48. Avenell A, MacLennan GS, Jenkinson DJ, et al. Long-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D3 and/or calcium (RECORD trial). J Clin Endocrinol Metab 2012;97:614-22.
49. Scragg R. Vitamin D and public health: an overview of recent research on common diseases and mortality in adulthood. Public Health Nutr 2011;14:1515-32.
50. Binkley N, Krueger D, Gemar D, et al. Correlation among 25-hydroxy-vitamin D assays. J Clin Endocrinol Metab 2008;93:1804-8. (Pubitemid 351656521)
51. Roth HJ, Schmidt-Gayk H, Weber H, et al. Accuracy and clinical implications of seven 25-hydroxyvitamin D methods compared with liquid chromatography-tandem mass spectrometry as a reference. Ann Clin Biochem 2008;45:153-9. (Pubitemid 351724586)
52. Carter GD. 25-Hydroxyvitamin D assays: the quest for accuracy. Clin Chem 2009;55:1300-2.
53. Sattar N, Welsh P, Panarelli M, et al. Increasing requests for vitamin D measurement: costly, confusing, and without credibility. Lancet 2012;379:95-6.
54. Sanders KM, Stuart AL, Williamson EJ, et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 2010;303:1815-22.
55. Michaelsson K, Baron JA, Snellman G, et al. Plasma vitamin D and mortality in older men: a community-based prospective cohort study. Am J Clin Nutr 2010;92:841-8.
56. van Diepen S, Majumdar SR, Bakal JA, et al. Heart failure is a risk factor for orthopedic fracture: a population-based analysis of 16 294 patients. Circulation 2008;118:1946-52.
57. Lyons KJ, Majumdar SR, Ezekowitz JA. The unrecognized burden of osteoporosis-related vertebral fractures in patients with heart failure. Circ Heart Fail 2011;4:62-7.